-
The search for better accommodations for my disease progression continues
If you’ve read my last few columns, you’ll know that I’m struggling with a lot
-
FDA Accepts sNDAs to Review Traditional Approval for AMONDYS 45 and VYONDYS 53
Today, Sarepta Therapeutics announced that the U.S. Food and Drug Administration (FDA) has accepted the








